The EDV is proving safe and effective across a number of late-stage, intractable cancers like pancreatic cancer and mesothelioma| Dr Jennifer MacDiarmid , CEO OF ENGENEIC 00:10:00
ennifer has raised more than $US 50 million in equity and provides employment for 34 scientists and ancillary staff in Sydney, Australia and New York, USA. She is the co-inventor on 435 granted international patents covering the technology to date.
